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ABSTRACT
Objectives: To evaluate the effectiveness of behaviour
changing interventions targeting ordering of thyroid
function tests.
Design: Systematic review.
Data sources: MEDLINE, EMBASE and the Cochrane
Database up to May 2015.
Eligibility criteria for selecting studies: We
included studies evaluating the effectiveness of
behaviour change interventions aiming to reduce
ordering of thyroid function tests. Randomised
controlled trials (RCTs), non-randomised controlled
studies and before and after studies were included.
There were no language restrictions.
Study appraisal and synthesis methods: 2
reviewers independently screened all records identified
by the electronic searches and reviewed the full text of
any deemed potentially relevant. Study details were
extracted from the included papers and their
methodological quality assessed independently using a
validated tool. Disagreements were resolved through
discussion and arbitration by a third reviewer. Meta-
analysis was not used.
Results: 27 studies (28 papers) were included. They
evaluated a range of interventions including guidelines/
protocols, changes to funding policy, education, decision
aids, reminders and audit/feedback; often intervention
types were combined. The most common outcome
measured was the rate of test ordering, but the effect on
appropriateness, test ordering patterns and cost were
also measured. 4 studies were RCTs. The majority of the
studies were of poor or moderate methodological quality.
The interventions were variable and poorly reported. Only
4 studies reported unsuccessful interventions but there
was no clear pattern to link effect and intervention type or
other characteristics.
Conclusions: The results suggest that behaviour
change interventions are effective particularly in reducing
the volume of thyroid function tests. However, due to the
poor methodological quality and reporting of the studies,
the likely presence of publication bias and the
questionable relevance of some interventions to current
day practice, we are unable to draw strong conclusions
or recommend the implementation of specific
intervention types. Further research is thus justified.
Trial registration number: CRD42014006192.
INTRODUCTION
Thyroid dysfunctions including hypothyroid-
ism and hyperthyroidism are among the most
common medical conditions with prevalence
3.82% (3.77–3.86%) and incidence 259.12
(254.39–263.9) cases per 100 000/year in
Europe.1 Both undertreatment and overtreat-
ment of these conditions may have serious
consequences for the patient’s health and,
therefore, correct and timely diagnosis and
monitoring are important.2 3
The diagnosis of thyroid dysfunctions, how-
ever, is challenging as they present with
common and non-speciﬁc symptoms: a
range of laboratory investigations, such as
thyroid-stimulating hormone (TSH), free
thyroxine (FT4) and free tri-iodothyronine
(FT3) are readily available to rule them in
Strengths and limitations of this study
▪ The current systematic review was conducted fol-
lowing the methods recommended by the
Cochrane Collaboration. We worked to a prespe-
cified protocol and consider our findings to be
robust.
▪ This is the first review focusing specifically on
the effectiveness of interventions designed to
reduce unnecessary ordering of thyroid function
tests.
▪ The evidence suggests that, in general, such
interventions are effective in reducing the
volume, changing the pattern of ordering,
improving compliance with guidelines or redu-
cing the cost of thyroid function tests ordered.
Whether such changes reflect more appropriate
test ordering remains unclear as measures of
appropriateness were rarely reported.
▪ However, the poor quality of evidence, the sig-
nificant heterogeneity in study design and the
likely presence of publication bias and selective
reporting did not allow strong conclusions and
more specific recommendations to be made and
precluded pooling the result from the individual
studies.
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or out. In the UK alone 10 million thyroid function
tests (TFTs) are ordered each year at an estimated cost
of £30 million.4
Although national guidelines for the use of TFTs exist,4
a recent audit of general practitioners’ (GPs) ordering pat-
terns conducted by our group in the South West of
England found that there is a sixfold variation in the rates
of test requests between different practices. The study also
demonstrated that only about 24% of this variation could
be accounted for by variation in the prevalence of hypo-
thyroidism and socioeconomic deprivation.5 The National
Health Service (NHS) Atlas of Variation in Diagnostic Services
published in November 20136 reported even more
extreme variation in the annual rate of TFTs ordered by
GPs per practice population across different primary care
trusts in England. In this report, the estimated annual rate
for TSH ordered by GPs ranged from 6.2 to 355.8 per
1000 practice population (57-fold variation). The reported
numbers for FT4 and FT3 were 14.6–231.1 (16-fold) and
0.42–17.0 (40-fold) per 1000 practice population, respect-
ively (p. 122).
A qualitative study we conducted identiﬁed a wide
range of mechanisms that might be responsible for the
variation, including the presence of inappropriate test
ordering.7 Given the continuous rise of thyroid test
requests,8 9 which is disproportionate to the increase in
the incidence and prevalence of thyroid conditions,9 and
the fact that these investigations make up a signiﬁcant
proportion of all laboratory tests ordered in primary
care,10 there is a need to help clinicians avoid inappropri-
ate thyroid testing. Such testing not only increases labora-
tory workload and wastes scarce resources but may also
have a negative impact on patients’ health through
further unnecessary tests and inappropriate treatment.11
The effectiveness of interventions designed to reduce
the number of unnecessary medical tests has already
been evaluated in a number of systematic reviews.12–16
Owing to their broad scope, however, the results are too
general and of little help when it comes to designing
interventions that target speciﬁc test ordering behaviour.
The effect of the same intervention may vary consider-
ably across different tests, even when they belong to the
same diagnostic modality.10 17–19 We conducted a system-
atic review investigating the effect of behavioural inter-
ventions on the ordering of TFTs. We believed a more
narrowly focused approach with respect to target behav-
iour might produce more applicable results and thus
better inform the development and implementation of
interventions speciﬁcally designed to improve TFT
ordering.
METHODS
In conducting the review, we followed the recommenda-
tions of the Cochrane Collaboration.20 MEDLINE,
EMBASE and the Cochrane Database of Systematic
Reviews were searched using a predeﬁned search strategy
(see online supplementary appendix 1). The original
search covered the period up until November 2013 and
was updated on 1 May 2015. Also, the bibliographies of
the included studies and other relevant publications
were scrutinised for additional articles. Studies were
selected independently by two reviewers (ZZ and RA)
with all disagreements resolved through discussion and,
if necessary, arbitration by a third reviewer (CH or BV).
In the ﬁrst round, all electronically identiﬁed citations
were screened at title and abstract level. Full-text copies
of potentially relevant articles were retrieved for full-text
screening. Studies were included in the review if they
met the following prespeciﬁed criteria:
▸ Evaluated the effectiveness of interventions designed
to reduce the number of inappropriately ordered
TFTs (regardless of whether they were the only tar-
geted tests or not).
▸ Were randomised controlled trials (RCTs), non-
randomised controlled studies or single-group before
and after studies (including both those with trend
before and after and those with just one time point
before and after).
▸ The outcomes were one or more of the following:
change in the total number of TFTs, the number of
inappropriately ordered tests, the test-related expend-
iture or health beneﬁts to individual patients (eg, the
number of unnecessary tests or treatments avoided).
▸ Reported the speciﬁc effect that the intervention had
on the targeted TFTs.
Studies that targeted TFTs along with other tests and
reported only the average effect (across all tests) were
excluded. We included all studies that used the rate of
inappropriately ordered TFTs as an outcome measure
regardless of the deﬁnitions they used. Appropriateness
of test ordering is usually judged against local protocols
or guidelines that may vary from place to place or
change over time. We accepted all deﬁnitions even when
they were outdated or did not ﬁt in with the current UK
guidelines. We did not use the setting and the targeted
clinicians’ characteristics as inclusion criteria but
explored, as far as possible, their potential impact on
the study outcomes. The methodological quality of the
included studies was assessed independently by ZZ and
RA using the Effective Public Health Practice Project
tool which allows the assessment of all study designs with
the same rubric.21 The method of synthesis was narra-
tive; meta-analysis was not used because of the antici-
pated clinical heterogeneity, particularly in terms of the
interventions. The framework for the analysis was based
on an existing typology of behaviour change interven-
tion types:12 15
▸ Educational interventions;
▸ Guideline and protocol development and
implementation;
▸ Changes to funding policy;
▸ Reminders of existing guidelines and protocols;
▸ Decision-making tools, including test request forms
and computer-based decision support;
▸ Audit and feedback.
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All work conformed with a protocol deﬁned and pub-
lished ahead of the review being started (PROSPERO,
registration number CRD42014006192).
RESULTS
The initial electronic searches produced 1282 hits of
which, after removing duplicates, 869 were screened at
title and abstract level and 99 were selected for full-text
screening. Twenty ﬁve of these papers, with two add-
itional papers identiﬁed through backward citation
searching, met our prespeciﬁed criteria, and were
included in the review.10 17–19 22–44 The update search
identiﬁed another 131 records of which, after screening
the titles and abstracts, 7 were selected for full-text
screening and 1 met the inclusion criteria.45 It should
be noted that two papers46 47 were excluded because
in these studies TFTs were allocated to the control
arm and, therefore, were not affected by the interven-
tions. Thus, the total number of papers included in the
review was 28 of which 2 reported on the same study,
the second reporting a long-term follow-up.30 31
The selection process and the reasons for full-text exclu-
sion are detailed in ﬁgure 1.
Study characteristics
The characteristics of the included studies are sum-
marised in table 1 and the evaluated interventions are
presented in table 2. Ten studies were conducted in the
USA, six in the UK and the rest in Australia (n=3),
France (n=3), Canada (n=2), the Netherlands (n=1),
Sweden (n=1) and New Zealand (n=1). All studies were
published in English, except for one in Dutch, which
was partly translated by a native Dutch speaker with a
background in healthcare research.38 The papers were
published between 197943 and 2014:45 seven of them
were published before 1991, nine between 1991 and
2000, and 12 after 2000. Fourteen studies were conducted
in a hospital setting including general and psychiatric
hospitals, medical assessment units, emergency depart-
ments and a supraregional liver unit, with the remainder
in primary care or community settings (table 1).
Education, guidelines/protocols and audit/feedback
were the most common types of intervention employed.
Reminders and decision tools were less commonly used
and changes to funding were assessed in only two
studies (table 2). Only three studies reported evaluation
of computer-based test ordering, two of which were
quite old, published in 198835 and 1994,32 respectively.
The recent one45 evaluated only a limited aspect of com-
puterised test ordering—the display of costs of tests
being ordered.
The median duration of the interventions was
12 months (IQR 6–12 months, range 2 days to
36 months) and four studies examined test ordering
after the intervention had ended.26 30 31 33 35
Description of the interventions was usually limited and
often insufﬁcient to allow replication. Where detail was
provided, it revealed signiﬁcant variability in the design
and implementation of interventions superﬁcially
belonging to the same category. For instance, educa-
tional interventions varied in terms of content, intensity
and frequency, method of delivery, who delivered and
who received the intervention as well as other character-
istics which are likely to affect their effectiveness and
appropriateness for different contexts and purposes.
Most interventions were targeted at both senior and
junior doctors. In four studies, only junior doctors were
included;24 26 27 32 four studies included other medical
staff, such as nurses, physician assistants and laboratory
technicians,17 23 30 33 and in one study, the intervention
was speciﬁcally directed at nurses41 (table 1).
In terms of targeted tests, 10 studies focused exclu-
sively on TFTs22 25 26 28 33 36 37 40 43 44 while the rest tar-
geted either a selection of laboratory tests suspected of
being overutilised or had a wider scope including
imaging as well as laboratory investigations. Of the tar-
geted TFTs, ﬁve studies focused exclusively on
TSH,10 26 32 35 45 two on TSH and FT4,23 38 four
reported an average result without specifying the individ-
ual tests18 24 34 41 and the remaining studies targeted
other combinations (table 1). As the studies spanned a
long period of time, different generations of tests were
used and the guidelines against which the appropriate-
ness of test ordering was judged varied. However, in
most studies, the recommended testing strategy was
based on TSH as a single ﬁrst-line test for suspected
thyroid dysfunction and for monitoring patients on
thyroid replacement hormones.Figure 1 Flow chart of the selection process.
Zhelev Z, et al. BMJ Open 2016;6:e010065. doi:10.1136/bmjopen-2015-010065 3
Open Access
Table 1 Characteristics of the included studies
Study and country Study design Setting Targeted test users Target tests Thyroid tests
Adlan et al,22 UK Before and after;
single site
Medical assessment unit
(acutely ill hospital
patients)
Physicians TFTs only TSH, FT4, FT3,
TPOAb, TRAb
Baker et al,23 UK Cluster RCT GP practices GPs, locums, GPs in training and
nurses
5 frequently ordered
laboratory tests suspected of
being inappropriately ordered
TSH and FT4
Berwick and Coltin,17
USA
Controlled cross-over;
3 sites
Ambulatory centres at
health maintenance
organisation
Internists and adult nurse
practitioners
13 laboratory and imaging
tests suspected of being
excessively ordered
TT4
Chu et al,24 Australia Before and after;
single site
Adult tertiary referral
teaching hospital ED
Interns and residents Frequently ordered blood
tests suspected of being
excessively ordered
TFTs unspecified
Cipullo and
Mostoufizadeh,19 USA
Before and after;
single site
Community hospital Medical staff (unspecified) A range of high-volume
laboratory procedures
TFTs unspecified but
change in TT3 rate
used as a measure
of impact
Daucourt et al,25 France Cluster RCT General and psychiatric
hospitals
Physicians TFTs only TSH, FT4, FT3, TRH
test
Dowling et al,26 USA Before and after;
single site
Innercity community health
centre
Family practice residents TSHs only (complete blood
count with differential used as
a comparator)
TSH
Emerson and
Emerson,27 USA
Before and after;
single site
University medical centre Residents All laboratory tests TSH, FT3, FT4, TT3,
TT4 (individual and
cascade)
Feldkamp and Carey,28
USA
Before and after;
single site
Metropolitan hospital and
22 satellite clinics
(inpatients and outpatients)
Physicians TFTs only TSH, TT3, TT4
Gama et al,18 UK Controlled study;
single site
District general hospital
(inpatients and outpatients)
General medicine physicians All laboratory tests TFTs unspecified
Grivell et al,29 Australia Before and after;
single site
Tertiary care community
hospital
Consultants 55 most commonly requested
laboratory tests or test groups
TT4
Hardwick et al,44
Canada
Before and after;
multiple sites
All non-hospital-based
laboratories in British
Columbia
All users of non-hospital-based
laboratories
TFTs only TT3, TT4
Horn et al,45 USA Interrupted time
series with a parallel
control group;
multiple sites
Alliance of 5 multispecialty
group practices
Primary care physicians 27 laboratory tests TSH
Larsson et al,30
Mindemark and
Larsson31 (follow-up),
Sweden
Before and after;
multiple sites
Primary healthcare centres GPs and laboratory technicians Various laboratory tests TSH, FT4, TT4, TT3
Continued
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Table 1 Continued
Study and country Study design Setting Targeted test users Target tests Thyroid tests
Nightingale et al,32 UK Before and after;
single site
Supraregional liver unit at
teaching hospital
House officers Various laboratory tests TSH
Rhyne and Gehlbach,43
USA
Before and after;
single site
Family medicine centre Physicians TFTs only Thyroid function
panel including TT4
and TT3
Schectman et al,33 USA Controlled study;
single site
Primary care health
maintenance organisation
Physicians, physician assistants
and nurse practitioners
TFTs only TSH, TT4, TT3
Stuart et al,34 Australia Before and after;
single site
Urban public hospital ED Consultants, registrars, junior
medical officers and casual
medical staff
All laboratory tests TFTs unspecified
Thomas et al,10 UK Cluster RCT Primary care practices in 1
NHS covered area
Family practitioners 9 laboratory tests suspected
of being inappropriately
ordered
TSH
Tierney et al,35 USA RCT; single site Academic general
medicine practice
Physicians (residents and faculty) 8 commonly ordered
diagnostic tests
TSH
Tomlinet al,36 New
Zealand
Controlled study;
multiple sites
New Zealand primary care All GPs on the New Zealand
Medical Council’s register
compared with locum GPs and
other medical specialists
TFTs only (but related
programmes targeted
inflammatory response tests
and tests for infectious
diarrhoea)
TSH, FT3, FT4
Toubert et al,37 France Before and after;
single site
Teaching hospital Physicians (various specialties,
including endocrinologists)
TFTs only TSH, FT3, FT4,
TPOAb, TRAb, TgAb
van Gend et al,38 The
Netherlands
Before and after;
multiple sites
GP practices in 1
geographical area
GPs 15 laboratory tests TSH, FT4
van Walraven et al,39
Canada
Retrospective
interrupted time
series; multiple sites
All private
non-hospital-based
laboratories in Ontario
Physicians ordering tests from
non-hospital laboratories
7 laboratory tests; 6
unaffected tests were chosen
as controls
TSH, TT4, TT3
Vidal-Trécan et al,40
France
Before and after;
multiple sites
A network of 50 non-profit
university hospitals in the
Paris region
Physicians TFTs only TSH, TT4, TT3, FT3,
FT4
Willis and Datta,41 UK Before and after;
single site
Medical admissions unit at
a district general hospital
Nurses Three potentially
inappropriately requested test
sets: thyroid profile, lipid
profile and coagulation
screen
Thyroid profile
(unspecified)
Wong et al,42 USA Controlled study;
single site
University teaching hospital Physicians TFTs, creatinine kinase and
lactate dehydrogenase
isoenzyme
TSH, TT4, TT3
ED, emergency department; FT3, free tri-iodothyronine; FT4, free thyroxine; GP, general practitioner; NHS, National Health Service; RCT, randomised controlled trial; TFTs, thyroid function
tests; TgAb, thyroglobin antibody; TPOAb, thyroid peroxidase antibody; TRAb, thyrotropin receptor antibody; TRH, thyrotropin-releasing hormone test; TSH, thyroid-stimulating hormone; TT3,
total tri-iodothyronine; TT4, total thyroxin.
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Table 2 Characteristics of the included studies: interventions
Study and country Setting
Educational
programmes
Guidelines
and protocols
Changes
to funding Reminders
Decision
tools
Audit and
feedback
Single-mechanism interventions
Adlan et al,22 UK Hospital X
Berwick and Coltin,17 USA* Primary care X XX
Chu et al,24 Australia Hospital X
Cipullo and Mostoufizadeh,19 USA Hospital X
Daucourt et al,25 France* Hospital X X
Emerson and Emerson,27 USA Primary care X
Feldkamp and Carey,28 USA Hospital X
Gama et al,18 UK Hospital X
Grivell et al,29 Australia Hospital X
Horn et al,45 USA Primary care X
Larsson et al,30 Mindemark and Larsson31
(follow-up), Sweden
Primary care X
Schectman et al,33 USA Primary care X
Tierney et al,35 USA Primary care X
Thomas et al,10 UK* Primary care X
Multifaceted interventions
Baker et al,23 UK Primary care X X
Daucourt et al,25 France* Hospital X X
Dowling et al,26 USA Primary care X X
Hardwick et al,44 Canada Primary care X X
Nightingale et al,32 UK Hospital X X X
Rhyne and Gehlbach,43 USA Primary care X X
Schectman et al,33 USA* Primary care X X X
Stuart et al,34 Australia Hospital X X X
Thomas et al,10 UK* Primary care X X
Tomlin et al,36 New Zealand Primary care X X X
Toubert et al,37 France Hospital X X
van Gend et al,38 The Netherlands Primary care X X
van Walraven et al,39 Canada Primary care X X X
Vidal-Trécan et al,40 France Hospital X X X
Willis and Datta,41 UK Hospital X X
Wong et al,42 USA Hospital X X
XX—two independent interventions of the same type.
*Study comparing directly two alternative interventions (Schectman et al33 had a non-comparative single-intervention design in its first phase and a multifaceted comparative design in the
second phase; Thomas et al10 compared a single-mechanism (reminders) vs multifaceted (feedback plus reminders) interventions; Daucourt et al25 compared two single-mechanism
interventions with their combination and usual practice defined as simple diffusion of guidelines).
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The effectiveness of the evaluated interventions with
respect to TFTs is summarised in table 3 with additional
information provided in table 4. The effect of the inter-
ventions was measured using a range of outcomes. Thus,
22 studies measured changes in the volume of test order-
ing expressed either as the absolute number of tests
ordered for a period of time or normalised by the
number of registered patients, visits or a similar param-
eter. To capture the effect on the pattern of test order-
ing, seven studies reported separate results for different
TFTs27 28 36 37 40 42 44 and three studies measured the
change in the ratios of two different tests (for instance,
whether the ratio ‘TSH:all TFTs’ has increased as a
result of new guidelines recommending TSH as a single
ﬁrst-line test).30 31 36 38 More direct evaluation of the
appropriateness of testing was carried out by measuring
adherence to protocols or guidelines25 26 32 33 37 43 with
two of these studies reporting underutilisation as well as
overutilisation.25 26 Five studies reported effectiveness in
terms of expenditure34–36 39 44 and one study reported
an estimate of the number of tests avoided as a result of
the intervention.39 In one study, researchers made an
effort to investigate whether the evaluated intervention
(in this case, a test-ordering protocol) had had any
adverse effects on patient outcomes by conducting an
audit of 4000 case notes and concluded that “No
adverse patient outcomes relating to underutilisation of
investigations attributable to the protocol were identi-
ﬁed.” (ref. 34, p. 133).
Study quality
The results from the methodological quality assessment
are presented in table 5. In terms of study design, four
were RCTs,10 23 25 35 ﬁve studies were non-randomised
controlled studies,17 18 33 36 42 two were interrupted time
series39 45 and the remaining were single-group studies
with just one time point measurement before and after.
Most of the studies were of poor or moderate quality;
the main issues being selection bias, lack of blinding
and failure to control for confounders.
Effectiveness of the interventions
Single-mechanism interventions
Fourteen studies10 17–19 22 24 25 27–31 33 35 45 evaluated
the effectiveness of the following single-mechanism
interventions (tables 2–4): educational programmes
(one controlled and two before and after
studies),17 30 33 guidelines and protocols (four before
and after studies),19 22 24 28 reminders (two RCT and
one controlled study),10 25 33 decision-making tools (two
RCTs, one interrupted time series and one before and
after study),25 27 35 45 and audit and feedback (two
controlled and two before and after studies).17 18 29 33
The study by Schectman et al33 was a two-stage study
before and after design in the ﬁrst part and a compara-
tive design in the second. The majority of the evaluated
single-mechanism interventions were effective in
decreasing test-related expenditure,35 the volume of test
ordering,17 18 22 24 27–29 33 changing the pattern of TFT
ordering19 27 28 30 31 or increasing compliance25 33 in
accordance with the recommended practice.
Two of these studies reported data on test ordering
once the intervention was discontinued. Mindemark
and Larsson31 investigated the effect of the 2-day educa-
tional programme originally evaluated by Larsson et al30
in a before and after study. Eight years after the pro-
gramme was delivered, they found that the ratios
between pairs of different TFTs was similar to that mea-
sured at the end of the original study (1 year after the
delivery of the programme). Only the ratio ‘TSH:all
TFTs’ showed slight but statistically signiﬁcant decrease
which the authors explained with the recommendation
given to participants to analyse TSH in elderly patients
who had not been tested in the previous 2–3 years
(table 4). Although impressive, the observed result is dif-
ﬁcult to explain with the educational programme alone
as other contextual factors are likely to have contributed
to the persistence of the effect.
Tierney et al35 reported that 6 months after the inter-
vention (display of computer-generated probability esti-
mates evaluated in an RCT) the difference between
intervention and control group has disappeared and the
main outcome—charges per scheduled visit—has
returned to baseline (table 4).
Three studies reported unsuccessful interventions: an
RCT of good methodological quality demonstrated that
a reminder in the form of a memorandum pocket card
was unsuccessful in increasing compliance with the
recommended thyroid testing strategy;25 a poor quality
before and after study showed that monthly feedback
given to consultants for a period of 1 year was unable to
decrease the ordering rates of a number of laboratory
tests;29 and an interrupted time series of moderate
methodological quality demonstrated that displaying the
cost of tests at the time of ordering was moderately
effective in a small number of tests but did not affect the
ordering of TFTs.45 The former two studies were con-
ducted in a hospital setting and the latter was a primary
care study.
The authors of the before and after study explained
the failure of the intervention by the prevailing institu-
tional culture; the fact that the clinical units ordering
the largest proportion of tests showed little concern and
attributed their requesting pattern to clinical workload
and the nature of their patients; and by the fact that the
feedback was provided to consultants only, on their
request, while many of the tests were ordered by junior
doctors unaffected by the intervention.29 The authors of
the interrupted time series study surveyed all interven-
tion and non-intervention physicians to investigate their
perceptions regarding the intervention and healthcare
costs in general. They found that while nearly all partici-
pants endorsed the need for cost containment and
found the display of costs informative, 50% of them
reported that the displays ‘rarely’ or ‘never’ impacted
their decision to order the tests.45
Zhelev Z, et al. BMJ Open 2016;6:e010065. doi:10.1136/bmjopen-2015-010065 7
Open Access
Table 3 Summary of results: effectiveness of the interventions with respect to thyroid function tests
Outcome Study Intervention Direction
Large
effect
Statistically
significant
change
RCT
design Notes on outcome measures
Single-mechanism interventions
Test numbers or
rates
Adlan et al22 Guidelines + + + − Per cent admissions offered TFTs
Berwick and Coltin17 Education (test
specific)
+ − NR − Per 100 encounters
Berwick and Coltin17 Feedback on cost + − NR − Per 100 encounters
Berwick and Coltin17 Feedback on yield − + NR − Per 100 encounters
Chu et al24 Guidelines + + + − Per 100 ED visits
Cipullo and
Mostoufizadeh19
Guidelines + − NR − Per discharge
Gama et al18 Feedback + + + − Per outpatient visit
Emerson and Emerson27 Request form
redesign
+ − + −
Feldkamp and Carey28 Guidelines + − NR − Per 1000 patients
Grivell et al29 Feedback − + NR −
Horn et al45 Display of cost of
tests being ordered
+ − − − Per 1000 visits
Schectman et al33 Educational
memorandum
+ − + − Per patient
Thomas et al10 Feedback + − + + Per 10 000 registered patients
Thomas et al10 Reminders + − + + Per 10 000 registered patients
Appropriateness
(compliance)
Daucourt et al25 Pocket memory
card
+ − − + Proportion of TFTs ordered in accordance with
the guidelines
Daucourt et al25 Request form
redesign
+ + + + Proportion of TFTs ordered in accordance with
the guidelines
Schectman et al33 Educational
memorandum
+ + + − Compliance with TSH-only strategy
Schectman et al33 Reminders + − + − Compliance with TSH-only strategy
Expenditure Tierney et al35 Display of
computer-
generated
probability
estimates
+ − − + Per visit
CV Berwick and Coltin17 Education (test
specific)
− − NR −
Berwick and Coltin17 Feedback on cost + + NR −
Berwick and Coltin17 Feedback on yield + + NR −
Pattern Emerson and
Emerson27
Request form
redesign
+ + NR − Sought to shift to TSH and thyroid cascade
Feldkamp and Carey Guidelines + + NR − Sought to shift to TSH and TSH-based algorithm
Larsson et al28 and
Mindemark and Larsson31
Years
1–2
Education + − + −
Continued
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Table 3 Continued
Outcome Study Intervention Direction
Large
effect
Statistically
significant
change
RCT
design Notes on outcome measures
Sought to shift to TSH; and reduce ordering of
TT3 and FT4 relative to TSH. Summary based on
TSH/all TFTs ratios
Larsson et al28 and
Mindemark and Larsson31
Years
2–6
Education − − + − Sought to shift to TSH; and reduce ordering of
TT3 and FT4 relative to TSH. Summary based on
TSH/all TFTs ratios
Multiple-mechanism interventions
Test numbers or
rates
Baker et al Education and
guidelines
+ − − + Per 1000 registered patients
Daucourt et al Pocket memory
card and request
form redesign
+ − + + Proportion of TFTs ordered in accordance with
the guidelines
Dowling et al26 Education and
feedback
+ − + − Per patient visit
Hardwick et al44 Funding policy and
guidelines
+ − NR −
Rhyne and Gehlbach43 Education and
guidelines
+ + + − Per 100 encounters
Schectman et al Feedback and
reminders
+ − + − Per patient
Thomas et al10 Feedback and
reminders
+ − + + Per 10 000 registered patients
Tomlin et al36 Education and
feedback and
guidelines
+ + + − Per year per GP
Toubert et al37 Guidelines and
reminders
+ + NR −
van Walraven et al39 Guidelines and
funding policy
+ + + − Summary based on decrease in the proportion of
TT4 and T3RU
van Walraven et al39 Guidelines and
request form
redesign
+ − + − Summary based on decrease in TSH utilisation
Vidal-Trécan et al40 Education and
guidelines and
request form
redesign
+ − NR − Summary based on the total number of TFTs
Willis and Datta41 Education and
guidelines
+ + + − Per admission
Wong et al42 Guidelines and
request form
redesign
+ + NR −
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Table 3 Continued
Outcome Study Intervention Direction
Large
effect
Statistically
significant
change
RCT
design Notes on outcome measures
Appropriateness
(compliance)
Dowling et al26 Education and
feedback
+ + + − Per cent TSH indicated
Nightingale et al32 Education and
feedback and
protocol
management
system
+ + NR − Per cent patients requiring a particular
investigation according to protocol who were
actually tested
Rhyne and Gehlbach43 Education and
guidelines
+ − − − Per cent ‘high’ and ‘low’ indications
Schectman et al33 Feedback and
reminders
+ − − −
Toubert et al37 Guidelines and
reminders
+ + + − Per cent appropriate
Expenditure Hardwick et al44 Funding policy and
guidelines
+ + NR −
Stuart et al34 Education and
feedback and
guidelines
+ + + −
Tomlin et al36 Education and
feedback and
guidelines
+ − NR −
Pattern Hardwick et al44 Funding policy and
guidelines
+ − NR − Sought to decrease proportion of TT3 as TFTs
requested. Summary based on per cent of TFTs
TT3
Tomlin et al36 Education and
feedback and
guidelines
+ + + − Sought to shift to TSH. Summary based on per
cent TFTs TSH alone
Toubert et al37 Guidelines and
reminders
+ + NR − Sought to shift to TSH. Summary based on per
cent TFTs TSH alone
van Gend et al38 Feedback and test
form redesign
+ + NR − Sought to shift away from TT4. Summary based
on FT4:TSH ratio
Vidal-Trecan et al40 Education and
guidelines and
request form
redesign
+ − NR − Sought to shift to TSH. Summary based on the
proportion of FT3 and TSH
Wong et al42 Guidelines and
request form
redesign
+ + NR − Sought to decrease ordering of ‘complete’ thyroid
panel to more selective use of individual tests
Direction: ‘+’ indicates result favours behaviour change intervention; ‘−’ opposite. Large effect: ‘+’ indicates risk difference is ≥20%; ‘−’ <20%. Statistically significant change: ‘+’ indicates 95%
CI do not include no effect or p<0.05; ‘−’ opposite. RCT design: ‘+’ indicates study design is RCT; ‘−’ not RCT.
CV, coefficient of variation; ED, emergency department; FT3, free tri-iodothyronine; FT4, free thyroxine; GP, general practitioner; NR, indicates item not reported; RCT, randomised controlled
trial; T3RU, tri-iodothyronine resin uptake; TFTs, thyroid function tests; TSH, thyroid-stimulating hormone; TT3, total tri-iodothyronine; TT4, total thyroxin.
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Table 4 Summary of results: additional information
Study and
country N at baseline
Intervention and
outcome measure Level at baseline Level postintervention Effect on outcome
Randomised controlled study designs
Baker et al23 UK Practices:
17 (I)
16 (C)
Intervention(s): G+FB
Measure(s): median (IQR)
number of TFTs per 1000
registered patients
17.4 (8.0, 39.5) (I)
22.7 (10.4, 30.9)
(C)
19.8 (6.2, 42.3) (I) at 6 months
19.5 (10.3, 31.1) (C) at
6 months
17.7 (6.6, 43.3) (I) at 9 months
17.3 (10.1, 34.0) (C) at
9 months
13.2 (6.3, 35.7) (I) at
12 months
20.9 (13.3, 35.3) (C) at
12 months
▸ For TFTs, the difference in mean change
in test rate from baseline to 4th quarter
was—1.45 in favour of the I (95% CI
−4.59 to 1.68) but was not statistically
significant (p=0.35)
▸ The intervention had no significant effect
on the other tests, too.
Daucourt et al,25
France
Hospital wards:
17 (PMC+TRF)
20 (TRF)
17 (MPC)
13 (C)
Intervention(s): PMC, TRF,
PMC+TRF
Measure(s): GCR
NA 77.9% (95% CI 68.9% to
87.0%) (MPC+TRF)
82.6% (95% CI 73.1% to
92.1%) (TRF)
73.4% (95% CI 56.7% to
90.1%) (MPC)
62.0% (95% CI 47.7% to
76.4%) (C)
▸ GCR was significantly higher in PMC
+TRF compared with the C (OR 2.65;
95% CI 1.52 to 4.62; p<0.01); slightly
lower compared with TRF and slightly
higher compared with MPC but the
differences were not statistically significant
▸ No difference between MPC and the C
(OR 1.28; 95% CI 0.75 to 2.19; p=0.37)
Thomas et al,10
UK
Practices:
21 (FB+R)
22 (FB)
22 (R)
20 (C)
Intervention(s): FB, R, FB+R
Measure(s): median (IQR) TFT
requests per 10 000 patients
per practice
750 (515–1329)
(C)
829 (476–1412)
(FB)
961 (476–1338)
(R)
891 (392–1277)
(FB+R)
795 (552–1466) (C)
802 (432–1359) (FB)
891 (490–1250) (R)
800 (287–1077) (FB+R)
▸ Is were significantly less likely to request
TFTs (FB group: OR 0.90 (0.84 to 0.97),
p=0.005; R group: OR 0.82 (0.83–0.95),
p=0.001).
▸ Across all targeted tests, intervention
practices were significantly less likely to
order tests.
Tierney et al,35
USA
Scheduled
visits:
7658 (I)
7590 (C)
Intervention(s): display of
computer-generated probability
estimates
Measure(s):
charges per scheduled visit (in
USA$)
NA 1.25 (C)
1.12 (I)
▸ TSH showed 10.3% decrease in charges
per visit in the I group but this difference
was not significant at p=0.05.
▸ Across all targeted tests, there was a
significant reduction in charges per visit
(−8.8%, p<0.05), with return to baseline at
3 months follow-up.
Non-randomised controlled study designs
Berwick and
Coltin,17 USA
35 internists and
30 adult nurses
at 3 centres
(total number of
visits not given)
Intervention(s): TSE, FBC and
FBY
Measure(s): per cent change in
the number of TT4 ordered per
100 encounters and the CV of
test ordering rates
TT4 tests per 100
encounters:
Site X: 72
Site Y: 72
Site Z: 45
Change: CV: ▸ TT4 use declined in the TSE and FBC
groups but increased in FBY; CV
decreased in FBC and FBY but increased
in the C group and showed very small
increase in TSE group. The statistical
significance of these results is NR.
C: +1.7% +15.7%
TSE: −15.9% +0.5%
FBC: −12.1% −23.6
FBY: +34.0% −28.2
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Table 4 Continued
Study and
country N at baseline
Intervention and
outcome measure Level at baseline Level postintervention Effect on outcome
Range of rates of
TT4 use:
Site X: 40–273
Site Y: 36–122
Site Z: 35–78
▸ Across all tests statistically significant
decline in test ordering (14.2%, p=0.012)
was observed only in the FBC group.
Gama et al,18
UK
Outpatient visits:
2991 (I)
4393 (C)
Intervention(s): FB
Measure(s): TFTs per
outpatient visit (mean, range)
0.17 (0.12–0.22) (I)
0.05 (0.04–0.06) (C)
0.13 (0.11–0.17) (I)
0.06 (0.05–0.08) (C)
▸ The mean number of TFTs per outpatient
visit decreased by 21.9% in the I group
(p<0.01) and increase by 20.8% (not
significant) in the C group.
▸ Similar results were obtained for the other
tests for outpatients but not for inpatients
(data NR).
Schectman
et al,33 USA
1425 patients,
30 clinicians
(group
distribution not
given)
Intervention(s): R and R+FB
Measure(s): Compliance
Mean (SE) number of TFTs
ordered per patient
68% (R)
65% (R+FB)
1.68 (0.04)
81% (R) at 6 months
77% (R) at 12 months
64% (R+FB) at 6 months
80% (R+FB) at 12 months
1.37 (0.03) at 2/12 (following
EM)
1.32 (0.05) at 6-month
follow-up
1.49 (0.04) at 1-year follow-up
▸ Significant increase in compliance in the
reminder group (p=0.05) but not in the R
+FB group; however, after excluding an
outlier both groups had similar increase in
compliance (77% vs 80%, p=0.39).
▸ The mean number of TFTs ordered per
patient also decreased significantly (no p
value given) but increased again at 1-year
follow-up (only data combining both
groups provided).
▸ TSH levels increased significantly while
TT4 and T3RU decreased but no details
are given.
Tomlin et al,36
New Zealand
GPs:
3140 (I)
2443 (C)
▸ Intervention(s): E+G+FB
▸ Measure(s): Tests per year
per GP:
TSH:
FT4:
FT3:
Total number of TFTs:
Ratios of different TFTs:
TSH/FT4
TSH/FT3
Expenditure (%)
223.6 (I)
33.8 (C)
144.2 (I)
29.1 (C)
41.6 (I)
11.0 (I)
NR
2.4:1
7.1:1
NR
215.2 (I)
32.0 (C)
80.7 (I)
25.3 (C)
26.6 (I)
9.4 (C)
21% decrease (I)
NR (C)
3.0:1
8.5:1
−19.8% (I)
−9.5% (C)
TSH showed small decrease (4%, p<0.01) in
the I group and no change in the C group
(p<0.11).
FT4 and FT3 decreased by 44.1% and
36.0%, respectively (p<0.01) in the I group
and 13.1% and 14.6%, respectively, in the C
group (p<0.01).
In the I group, the proportion of TSH as the
sole test ordered increased from 43.2% to
65.2% (p<0.001). Ratios of TSH to FT4
increased from 2.4:1 to 3.0:1 and TSH to
FT3 from 7.7:1 to 8.5:1. Simultaneous testing
of TSH and FT4 and/or FT3 decreased by
41.1% and there was a decrease in the net
TFT expenditure (no p values given).
Wong et al,42
USA
NR Intervention(s): G+TRF
Measure(s): tests per month
Intervention tests
(months to
Intervention tests (months
after intervention was
Distributing guidelines through a bulletin
alone failed to produce effect but in
Continued
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Table 4 Continued
Study and
country N at baseline
Intervention and
outcome measure Level at baseline Level postintervention Effect on outcome
intervention):*
T4 (RIA) and
T3RU:
9 months : 1100
6 months: 1150
3 months: 1100
TSH:
9 months: 900
6 months: 1300
3 months: 900
T3 (RIA):
9 months: 950
6 months: 1000
3 months: 900
Control tests:*
CK:
9 months: 1000
6 months: 980
3 months: 980
LDH:
9 months: 650
6 months: 700
3 months: 750
introduced):*
T4 (RIA) and T3RU:
At 2 months: 1000
4 months: 1000
6 months:1100
8 months:950
TSH:
2 months: 500
4 months: 500
6 months:600
8 months:500
T3 (RIA):
2 months: 200
4 months: 300
6 months: 400
8 months: 300
Control tests*:
CK:
2 months: 1100
4 months: 700
6 months:1000
LDH:
2 months: 700
4 months: 500
6 months:700
combination with request form redesign it led
to restructuring of test ordering patterns with
decrease of ‘complete’ thyroid panel and
increase of hyperthyroid and hypothyroid
panels and thyroid function screen.
No changes in T4 (RIA) and T3RU but the
number of T3 (RIA) and TSH tests ordered
per month fell on the average to 38% and
61%, respectively, of the mean monthly rates
at which these tests had been ordered in the
preceding 18 months.
No changes were observed in the ordering of
the control tests. Statistical significance of
the above results is NR.
Not all data presented here!
Interrupted time series
Horn et al,45 Average monthly
orders per 1000
patient visits
(TSH):
174.1 (I)
140.3 (C)
Intervention: display of cost of
tests being ordered
Measure(s): comparison of
change-in-slope of the monthly
ordering rates between
intervention and control
physicians for 12 months
preintervention and 6 months
postintervention
Per cent change in
monthly order
rates (TSH,
preintervention):
0.2% (I)
0.1% (C)
Per cent change in monthly
order rates (TSH,
postntervention):
0.5% decrease (I)
0.4% increase (C)
The difference in the rate of change
preintervention to postintervention was 0.7%
decrease in the I group and 0.3% increase in
the C group; none of these results was
significant at p value <0.002 (2-sided
Bonferroni-adjusted p value).
Across all 27 evaluated tests, a statistically
significant modest decrease in ordering rates
of intervention physicians compared with
control physicians was observed in 5 tests.
Van Walraven
et al,39 Canada
NR Intervention(s): G+CFP; G+TRF
Measure(s): avoided tests, utilisation rate and cost
1 July 1991:
TSH: 1 per 100
persons*
TT4: 1.2 per
100 persons*
G+CFP:
TT4: 4359
(95% CI
−14 to
23 430)
G+CFP led to 96% decrease in the TT4
utilisation (p=0.02) and decrease in T3RU.
Guidelines plus removing TSH ‘tick box’ from
the request form resulted in 12% decrease in
TSH utilisation (p=0.03).
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Table 4 Continued
Study and
country N at baseline
Intervention and
outcome measure Level at baseline Level postintervention Effect on outcome
tests
avoided
T3RU: 3073
(−28 to
18 153)
tests
avoided
G+TRF:
TSH: 2200
(95% CI
−1638 to
6039) tests
avoided
All interventions together resulted in a
decrease of 626 098 tests, which saved
$2 010 400, including $29 664 in the final
year.
Before and after study designs
Adlan et al,22
UK
Admissions:
1593 (pre)
1176 (post)
Intervention(s): G
Measure(s): proportion of
admitted patients offered TFTs
53.8% (857 out of
1593)
21.7% (255 out of 1176) Significant reduction (32.1%, p<0.001) in the
proportion of admitted patients offered TFTs
Chu et al,24
Australia
ED visits:
24 652 (pre)
25 576 (post)
Intervention(s): G
Measure(s): mean number of
TFTs ordered per 100 ED visits
2.2 (20-week
preintervention
period)
1.6 (20-week postintervention
period)
Significant reduction in the mean number of
TFTs (0.6 tests per 100 ED presentations,
p=0.001)
The mean number of all blood tests ordered
per 100 ED presentations fell by 19%
(p=0.001) and the mean cost fell by 17%
(p=0.001).
Cipullo and
Mostoufizadeh,39
USA
NA Intervention(s): G
Measure(s): mean tests
utilisation (T3 per discharge)
0.006 (1 year
before)
0.005
(1 year after)
The number of T3 uptake per discharge
decreased by 17%.
Most of the other targeted tests also showed
decline in utilisation. Statistical significance
NR.
Dowling et al,26
USA
Patient visits:
10 961 (pre),
6606
(post),3024 (at
5 months
follow-up)
Intervention(s): E+FB
Measure(s):
proportion of indicated TSH
(out of all TSHs performed)
Rate of TSHs ordered per
patient visit (total number of
TSHs and visits)
Rate of indicated TSH per visit
Rate of non-indicated TSHs
per visit
28% (25 of 90)
1 per 122 (90 in
10 961)
1 per 438
1 per 169
65% (15 of 23)
43% (9 of 21) (at 5 months
follow-up)
1 per 287 (23 in 6 606)
1 per 178 (21 in 3 024)
(at 5 months follow-up)
1 per 440
1 per 336 (at 5 months
follow-up)
1 per 826
1 per 252 (at 5 months
follow-up)
The proportion of indicated TSHs increased
significantly (p<0.001) while TSHs per
patient visit decreased significantly
(p<0.0001) in the intervention period but both
showed some decline at 5 months follow-up.
The rate of indicated TSHs per visit did not
change significantly while the rate of
non-indicated TSHs per visit decreased
drastically in the intervention period but
increased again at follow-up.
Data for the control test, CBC with
differential, is not shown here but the rate of
Continued
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Table 4 Continued
Study and
country N at baseline
Intervention and
outcome measure Level at baseline Level postintervention Effect on outcome
ordering showed steady decline even in the
follow-up and the rates of ordering both
indicated and non-indicated CBCs decreased
at the end of the intervention, although the
statistical significance of these results was
NR.
Emerson and
Emerson,27 USA
Unclear Intervention(s): TRF
Measure(s): number of tests/
panels ordered preintervention
to postintervention
TSH: 5300*
FT4: 750
TT4: 1700
TT3: 800
FTI/T3RU: 900
TFT cascade: NA
Combined TSH
and cascade: 5250
TSH: 3000*
FT4: 1450
TT4: 200
TT3: 500
FTI/T3RU: 100
TFT cascade: 1700
Combined TSH and cascade:
4750
TFT testing decreased significantly (p<0.01)
with a shift towards FT4 and thyroid cascade.
Across all tests, the total number of tests
remained the same (due to an increase in
the number of patients) but the number of
tests per patient visit showed significant
decrease (p<0.01).
Feldkamp and
Carey,28 USA
Sequential TFT
requests:
1000 (pre)
463 (post,
1 year)
625 (post,
3 years)
Intervention(s): G
Measure(s):
percentage of different TFTs
and combinations:
Prealgorithm: 1 year 2 years ‘TSH only’ and DRTSH accounted for 92.4%
of all TFTs 3 years after the introduction of
the algorithm. The other combinations
gradually decreased. However, the statistical
significance of these results is NR.TFT only 33.3% 44.8% 32.2%
DRTSH algorithm – 24.4% 60.2%
TSH+TT4+T3RU 16.6% 3.9% 1.3%
TT4 only 10.0% 4.8% 0.8%
TT4+T3RU 6.8% 2.8% 1.1%
Others (including TT3) – – 3.0%
TFTs per 1000 patients: Prealgorithm: Postalgorithm:
DRTSH:
Tests/1000
TSH 832 982 1000
TT4 667 216 202
T3RU 234 159 202
Total 1 733 1359 1404
Difference – 374 329
Grivell et al,29
Australia
NR Intervention(s): FB
Measure(s): ratio of thyroxin
requests postintervention to
preintervention
NA 1.20 Thyroxin requests in the postintervention
period were 1.2 times the requests in the
preintervention period but the statistical
significance of this result was NR.
Hardwick et al,44
Canada
NR Intervention(s): G+CFP
Measure(s): proportion
(number) of different TFTs:
1974/75 1976/77 1978/79 Overall decline from baseline to 3 years
postintervention (1978/79) with shift towards
TT4 which accounted for 80.4% of all TFT
investigations in the last period.
Expenditure also decreased to 34% of the
TT3 21.8% (29 004) 19.0% (35 101) 4.7% (7502)
TT4 51.8% (68 912) 50.8% (93 988)
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Table 4 Continued
Study and
country N at baseline
Intervention and
outcome measure Level at baseline Level postintervention Effect on outcome
expected charges by the end of the study
period. The statistical significance of these
results was NR.
80.4%
(128 343)
ETR 26.4% (35 183) 30.2% (55 798) 14.9%
(23 703)
Total 100% (133 099) 100%
(184 887)
100%
(159 548)
1975/76 1977/78
TT3 20.4% (33 334) 11.8% (19 255)
TT4 49.6% (81 004) 62.3% (101 805)
ETR 29.8% (48 832) 25.9% (42 346)
Total 100% (163 170) 100%
(163 406)
Horn et al,45 Physicians:
153 (I)
62 (C)
Intervention(s): Display of cost
of tests being ordered
(computer-based ordering
system)
Measure(s): difference in per
cent change in monthly orders
between I and C group (orders
per 1000 patient visits)
Baseline average
monthly order rate
(orders per 1000
visits):
174.1 (I)
140.3 (C)
Per cent change in
monthly order rate:
0.2% (I)
0.1% (C)
Per cent
change in
monthly order
rate:
−0.5% (I)
0.4% (C)
Difference:
−0.7% (I)
0.3% (C)
Monthly order rates for TSH decreased
slightly in the I group and increased in the C
group but the difference was not statistically
significant (p=0.04; because 27 tests were
analysed, the study used a 2-sided
Bonferroni-adjusted p value of <0.002 to
determine statistical significance).
Larsson et al,30
Sweden
19 primary care
centres
Intervention(s): E
Measure(s): mean ratios of the
requests for related tests:
1996 1997 Significant decrease in TT3/TSH (difference
between mean ratios 0.073, SD=0.089,
p=0.0012) and non-significant decrease in
FT4/TSH (difference 0.032, SD=0.116,
p=0.13).
As recommended, the ratio of TSH to all
TFTs increase significantly (difference
−0.017, SD=0.041, p=0.048).
TT3/TSH 0.129 0.056
FT4/TSH 0.333 0.301
TSH/total number of TFTs 0.124 0.141
Mindemarkand
Larsson31
(follow-up of
Larsson 1999)
Median ratios: 1997 2004 7 years after the intervention TT3/TSH and
(TT4+FT4)/TSH were not significantly
different from those at the end of the original
study period, thus showing no decay in the
intervention’s effect. However, THS/all TFTs
showed slight decrease (difference −0.043)
which was statistically significant (p<0.05).
Most of the other tests’ ratios also remained
stable.
TT3/TSH 0.029 0.022
(TT4+FT4)/TSH 0.273 0.237
TSH/all TFTs 0.115 0.072
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Table 4 Continued
Study and
country N at baseline
Intervention and
outcome measure Level at baseline Level postintervention Effect on outcome
Nightingale
et al,32 UK
Number of
patients: 654
(before) 833
(after)
Intervention(s): PMS+E+FB
Measure(s): change in
compliance
55%* 85%* Compliance of TSH requests increased but
results are given only as a graph and the
statistical significance is NR.
Across all tests, the total number of tests
requested per patient day declined by 17%
(p<0.001).
Rhyne and
Gehlbach,43
Canada
NR Intervention(s): G+E
Measure(s):
▸ TFPs per 100 encounters
▸ Proportion of:‘high
indications’‘low indications’
October to
December 1976
1.00
January to March
1977
Approximately 1.10
45%
29%
June to August 1977
Approximately 0.70
September to November 1977
Approximately 1.00
53%
19%
Significant decrease in the number of TFP
ordered per encounter in the 3 months after
the intervention (p<0.05) but return to
baseline in the following 3 months. Results
given only as a graph. The proportion of FTP
for ‘high indications’ increased and that for
‘low indications’ decreased but was not
statistically significant (p<0.05). Senior
residents decreased their TFP ordering rate
while that of junior residents increased
(p<0.05).
Schectman
et al,33 USA
1425 patients,
30 clinicians
(group
distribution not
given)
Intervention(s): EM
Measure(s): compliance rate
Mean (SE) number of TFTs
ordered per patient
35%
1.68 (0.04)
67% at 2 months (following
EM)
1.37 (0.03) at 2 months
(following EM)
1.49 (0.04) at 1 year follow-up
▸ Significant increase in compliance after
EM (p<0.0001)
▸ The mean number of TFTs ordered per
patient decreased significantly following
EM (p<0.0001) and showed further
decline at 6 months after the subsequent
interventions (see under Non-randomised
controlled studies above) but increased
again at 1 year follow-up.
▸ The educational intervention had greater
impact on nurses and physician assistants
than physicians (absolute increase in
compliance 63% vs 28%).
Stuart et al,34
Australia
NR; annual
census of
42 500 patients
Intervention(s): E+G+FB
Measure(s): mean cost of TFT
(in $A) per patient
0.426 0.047 TFT ordering decreased by 89% and showed
a significant decrease in cost per patient
(−89% difference (95% CI −55% to −123%;
p<0.001).
Across all tests, there was 40% decrease in
the ordering of tests with test utilisation
falling from a mean of $39.32/patient to
$23.72/patient (p<0.001). Tests not allowed
to be ordered for ED patients, such as TFT,
showed the greatest decrease. The effect
was sustained at 18 months follow-up.
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Table 4 Continued
Study and
country N at baseline
Intervention and
outcome measure Level at baseline Level postintervention Effect on outcome
Toubert et al,37
France
800-bed hospital
with annual
census of
25 266
inpatients and
242 013
outpatients
Intervention(s): G+R
Measure(s):
number of TFTs:
1996 1997 1998 A substantial decrease in the total number of
TFTs mainly due to a decrease in the
number of FT3 and FT4; a decrease in the
relative proportion of FT3. Single TSH order
forms increased from 23% to 50%, while
TSH+FT4+FT3 decreased. The statistical
significance of these results was NR.
The percentage of appropriate tests
increased from 42.5% (95%CI 39.9% to
45.1%) in 1996 to 72.4% (95%CI 69.8% to
75%) in 1997 (p<0.0001) but there was
some decrease in 1998 (no p value given).
(Data for thyroid antibodies is not presented
here.)
Total TSH tests 1329 1119 1062
Total FT4 tests 1011 535 539
Total FT3 tests 715 247 226
Total number of TFTs 3145 1901 1827
Patterns:
Single TSH 305 563 512
TSH+FT4 319 313 333
TSH+FT3 23 25 20
TSH+FT4+FT3 682 218 197
FT4+FT3 10 4 9
All TFT request forms 1339 1123 1071
Appropriateness: 42.5% 72.4% 70.7%
van Gend
et al,38 The
Netherlands
NR Intervention(s): TRF+FB
Measure(s): ratio of FT4
(removed from) to TSH (left on
the request form)
1992
0.96 (2498:2608)
1993
0.31 (1180:3747)
1994
0.28 (1436:5040)
There was a decrease in the FT4:TSH ratio
indicating that the intervention had impact on
test ordering patterns but the statistical
significance of the results was NR.
Vidal-Trécan
et al,40 France
June 1995:
all TFTs: 27 945
Intervention(s):
E+G+TRF
Measure(s):
number (%) of TFTs
June 1995 June 1998 11% decrease in the total number of TFTs
even though the number of admissions
increased by 2% and the number of
outpatient visits by 6%.
The proportion of FT4 tests remained the
same (33%); the proportion of FT3
measurements decreased by 6% and the
proportion of TSH tests increased. The
statistical significance of the results was NR.
Total TFTs 100% (27 945) 88.7% (24 794)
FT3 20% (5491) 14% (3534 of 24 794)
TT3 1% (339) 1% (371 of 24 794)
FT4 33% (9301) 33% (8125 of 24 794)
TT4 2% (478) 1% (238 of 24 794)
TSH 44% (12 336) 51% (12 526 of 24 794)
Willis and
Datta,41 UK
An average of
950 patients and
309 thyroid
profiles per
month
Intervention(s): E+G
Measure(s): mean (SD)
number of TFT profiles per
admission
0.32 (0.05) 0.08 (0.01) Significant decrease in the number of
requested thyroid profiles (p<0.001).
Across all tests, a significant change
between the total number of sets requested
per admission before (7.5 (0.87)) and after
the intervention (5.9 (0.33)), p<0.001.
*Approximate reading off a graph.
C, control group; CBC, complete blood count; CFP, changes to funding policy; CK, creatinine kinase; CV, coefficient of variation; DRTSH, directed thyroid testing algorithm; E, education; ED,
emergency department; EM, educational memorandum; ETR, effective thyroxin ratio; FB, feedback; FBC, feedback on cost; FBY, feedback on yield; FT3, free tri-iodothyronine; FT4, free
thyroxine; FTI, free thyroid index; G, guidelines/protocol; GCR, guideline conformity rate, the proportion of TFTs ordered in accordance with the guidelines; GP, general practitioner; I,
Intervention group; LDH, lactic dehydrogenase isoenzyme; NA, not available; NR, not reported; PMC, pocket memory card; PMS, protocol management system; R, reminders; T3 (RIA),
tri-iodothyronine radioimmunoassay; T3RU, tri-iodothyronine resin uptake; T4 (RIA), thyroxin radioimmunoassay; TFP, thyroid function panel; TFTs, thyroid function tests; TRF, test request form
redesign; TSE, test-specific education; TSH, thyroid-stimulating hormone; TT3, total tri-iodothyronine; TT4, total thyroxin.
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Berwick and colleagues who compared two different
types of feedback, on cost and on yield, with test-speciﬁc
education reported mixed results. Across all tests, only
feedback on cost showed statistically signiﬁcant effect,
whereas for the TFTs test-speciﬁc education had the
largest effect. With regard to reducing variability in test
ordering, the two forms of feedback but not education
led to a positive change. The statistical signiﬁcance of
the results speciﬁc to TFTs, however, was not reported.17
Multifaceted interventions
Sixteen studies evaluated interventions that relied on
more than one mechanism to change test ordering
behaviour (tables 2–4).10 23 25 26 32–34 36–44 Ten of them
combined the introduction of guidelines or protocols
with audit and feedback,23 education,41 43 redesign of a
test request form,39 42 changes to funding policy,39 44
education plus audit and feedback,34 36 reminders,37 or
education plus a test request form.40 Of the remaining
six studies, three evaluated the combination of audit
and feedback with education,26 reminders10 or a
problem-oriented test request form;38 one study evalu-
ated the effectiveness of a computer-based protocol
management system enhanced with audit and feedback
and education;32 one compared an educational memo-
randum followed by a reminder with the same educa-
tional memorandum followed by a reminder and
feedback;33 and one compared a combination of pocket
memory card (reminder) and redesign of test request
form with the same single-mechanism interventions and
usual practice deﬁned as simple diffusion of
guidelines.25
With the exception of one study,23 all reported that
the evaluated multifaceted interventions were effective
in decreasing the volume of test ordering,10 23 26 33 36 37
39–41 43 44 changing the pattern of test ordering in
Table 5 Results from the methodological quality assessment of the included studies using the EPHPP tool
Study
Selection
bias
Study
design Confounders Blinding
Data
collection
method
Withdrawals
and dropouts
Global
rating
Randomised controlled trials
Baker et al23 Strong Strong Strong Moderate Strong Strong Strong
Daucourt et al25 Moderate Strong Strong Strong Moderate Strong Strong
Thomas et al10 Strong Strong Strong Strong Strong Strong Strong
Tierney et al35 Strong Strong Strong Moderate Strong Strong Strong
Non-randomised controlled studies
Berwick and
Coltin17
Moderate Strong Moderate Weak Strong Weak Weak
Gama et al18 Weak Moderate Weak Weak Strong Strong Weak
Schectman et al33 Moderate Strong Weak Moderate Strong Strong Moderate
Tomlin et al36 Strong Strong Weak Moderate Strong Moderate Moderate
Wong et al42 Weak Moderate Weak Moderate Strong Weak Weak
Interrupted time series
Horn et al45 Moderate Moderate Moderate Weak Strong Moderate Moderate
van Walraven et al39 Strong Moderate Moderate Strong Strong Strong Strong
Before and after studies
Adlan et al22 Weak Moderate Weak Moderate Strong Weak Weak
Chu et al24 Weak Moderate Weak Moderate Strong Weak Weak
Cipullo and
Mostoufizadeh19
Weak Moderate Weak Weak Weak Weak Weak
Dowling et al26 Weak Moderate Weak Weak Weak Strong Weak
Emerson and
Emerson27
Weak Moderate Weak Weak Strong Weak Weak
Feldkamp and
Carey28
Weak Moderate Weak Weak Strong Weak Weak
Grivell et al29 Weak Moderate Weak Weak Strong Weak Weak
Hardwick et al44 Strong Moderate Moderate Strong Strong Strong Moderate
Larsson et al30 Moderate Moderate Weak Moderate Strong Strong Moderate
Nightingale et al32 Weak Moderate Weak Weak Strong Weak Weak
Rhyne and
Gehlbach43
Weak Moderate Weak Moderate Strong Weak Weak
Stuart et al34 Weak Moderate Weak Moderate Moderate Moderate Weak
Toubert et al36 Weak Moderate Weak Moderate Moderate Weak Weak
van Gend et al38 Strong Moderate Weak Moderate Strong Strong Moderate
Vidal-Trécan et al40 Moderate Moderate Moderate Moderate Strong Strong Strong
Willis and Datta41 Weak Moderate Weak Moderate Strong Weak Weak
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accordance with the recommended practice,26 33 37–
40 42–44 avoiding unnecessary testing39 and/or decreas-
ing test-related expenditure.34 36 39
Two before and after studies reported data on test
ordering once the intervention was discontinued.26 33
Dowling and colleagues evaluated the effectiveness of
education plus feedback and measured the rate of TSH
ordered per patient visit and the indicated and non-
indicated TSH per visit. Despite the initial statistically
signiﬁcant effect, 5 months after the intervention was
discontinued, all indicators showed some decline.
Schectman et al33 evaluated the effect of educational
memorandum followed by reminder or reminder and
feedback on compliance and the mean number of TFTs
ordered per patients. The interventions increased com-
pliance and led to signiﬁcant decrease in test ordering
which continued 6 months after the interventions but
increased again at 1 year follow-up (table 4).
The study that reported an unsuccessful intervention
was an RCT of good methodological quality and was con-
ducted in primary care. It targeted the use of ﬁve fre-
quently ordered laboratory tests including TSH and FT4
and evaluated the effectiveness of a combination of
guidelines and feedback. The authors explained the
failure of the intervention by the following: the feedback
was provided for 1 year only, the participating practices
did not volunteer to take part in the study and the
guidelines might not have been sufﬁcient to predispose
physicians to change their test ordering behaviour.23
Owing to the signiﬁcant heterogeneity and poor meth-
odological quality of the studies, we deemed pooling the
results inappropriate and were unable to use statistical
methods to investigate the impact of various study and
intervention characteristics on the reported outcomes.
Visual inspection of the data suggests, however, that dif-
ferences such as intervention type, study design, setting
and year of publication have little or no impact on the
reported effectiveness. We created a spreadsheet which
can be used by the readers to explore this themselves by
sorting the results according to different study character-
istics (see online supplementary appendix 2).
DISCUSSION
Main findings
This systematic review of behaviour change interventions
designed to modify the ordering of TFTs found 27
studies. Several intervention types were evaluated includ-
ing education, guidelines and protocols, audit and feed-
back, decision-making tools, changes to funding policy
and reminders, either alone or in combination, in either
primary or hospital care, and targeting clinicians of dif-
ferent seniority. Most of the studies were of poor or
moderate quality and many of the interventions were
poorly described.
In these studies, it appears that behaviour change
interventions were, in general, effective in reducing the
volume, changing the pattern of test ordering,
improving compliance with guidelines or reducing the
cost of TFTs ordered. Whether such changes reﬂect
more appropriate test ordering, however, was unclear as
in the majority of studies measures of appropriateness
were undeﬁned, and thus unreported. No study investi-
gated directly any impact on patient outcomes. Only ﬁve
studies observed the effect of the intervention on test
ordering for more than 12 months28 34 36 37 44 and only
four reported the persistence of effect once the inter-
vention had ended,26 30 31 33 35 of which three reported
return to baseline or decline within 1 year.26 33 35
Although not the subject of an a priori subgroup ana-
lysis, multifaceted interventions did not appear to be
more effective than single-mechanism ones. The speciﬁc
type of intervention(s) appeared less important than the
interaction between various intervention-speciﬁc vari-
ables and the implementation of the intervention in a
speciﬁc context. For instance, feedback could be very
successful if there was a strong institutional support for
change26 or completely ineffective if the changes it was
trying to introduce clashed with the dominant institu-
tional culture.29 Even within a single study, the same
intervention performed differently in different clinical
circumstances (eg, inpatients vs outpatients)18 or differ-
ent interventions seemed to be effective for different
type of tests.17 45 As Mindemark and Larsson31 put it “…
the most decisive factor for the success of a strategy in
optimizing test ordering is not the nature of the inter-
vention itself, but rather its design and implementation
in a given setting.” (p. 485)
The effectiveness of the interventions depended to
some extent on the outcomes the researchers had
chosen to measure. These outcomes reﬂected speciﬁc
assumptions about what constitutes inappropriate test
ordering and how this could be changed.
‘Appropriateness’ is to a large extent, a value judgement,
incorporating elements of importance of the diagnosis,
beneﬁts from early diagnosis (and the converse, harms
from delays in diagnosis), burden and unpleasantness of
the test, plus economic considerations. These aspects
were rarely—if ever—explicitly reported as part of
the rationale for the intervention and selection of the
outcome measure. It was simpler to examine the volume
of testing or the shift in the pattern of TFTs ordered
which most studies did, but clinically, this is a blunt
measure of appropriateness.
For instance, in one study a one-off educational event
encouraged GPs to use TSH as a single ﬁrst-line test30
and the intervention was reported to have a long-term
effect.31 The following ratios were used as an outcome
measures: ‘TSH:all TFTs’ (which was expected to
increase) and ‘T3:TSH’ and ‘FT4:TSH’ (which were
expected to decrease as a result). Therefore, the inter-
vention did not address inappropriate ordering of TSH
and the chosen outcomes could not capture a possible
‘shift’ where doctors ordered inappropriately more
TSHs while ordering fewer T3 and FT4 tests. An inter-
rupted time series analysis which investigated the effect
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of a series of interventions over a period of several years
clearly demonstrates such a possibility.39
Strengths and limitations of study
We conducted the current systematic review using the
methods recommended by the Cochrane Collaboration
working to a prespeciﬁed protocol and consider our
ﬁndings to be robust. This is the ﬁrst review focusing
speciﬁcally on the effectiveness of interventions
designed to reduce unnecessary ordering of TFTs. The
identiﬁed evidence is directly relevant to this particular
test ordering behaviour and could be used to guide the
design and implementation of future intervention pro-
grammes as well as the development of research projects
that could address the identiﬁed gaps in knowledge.
The main limitation is that the quality of evidence did
not allow strong conclusions and more speciﬁc recom-
mendations to be made. Furthermore, the disparate
methods, populations of study, interventions and
outcome measures made pooled synthesis of results
impossible. Thus, we have chosen to present the results
as a narrative synthesis. Similarly, although we strongly
suspect that publication bias and selective reporting of
outcomes may be operating, particularly for the non-
randomised study designs, we could neither investigate
nor attempt to quantify the potential impact. We think it
is likely that publication bias has exaggerated the results,
but is highly unlikely to completely account for the
overall beneﬁcial pattern observed. That the more rigor-
ous designs gave less marked and even negative results
(tables 3 and 4 and online supplementary appendix 2)
adds a note of caution however.
Comparison with other studies
We are not aware of another systematic review with a
similar focus. Other systematic reviews have examined
the effectiveness of behavioural interventions designed
to inﬂuence test ordering as a whole.12–16 Our review
focused on a speciﬁc diagnostic scenario—the use of
laboratory tests to diagnose and monitor thyroid
dysfunction.
Clinical interpretation of the results
Superﬁcially, based on the predominant pattern of
favourable results from the included studies, there
would seem to be little doubt that where there is evi-
dence that TFTs ordering needs to be modiﬁed, the
interventions employed in the included studies could be
used to effectively reduce volume, improve compliance,
change the pattern of testing or reduce cost. However,
we believe some caution is required. The most funda-
mental issue is that in many included studies, the detail
about the nature of the intervention is insufﬁcient for
implementation; the situation is particularly acute where
the target behaviour is appropriateness, because the
value of achieving compliance is completely dependent
on the deﬁnition of appropriateness being used and
how it was derived. The problem concerning insufﬁcient
deﬁnition of the intervention has been noted before
and is, we believe, particularly relevant here.48 Although,
additional details may exist outside the published paper
and be obtained through personal contact with the
investigators, much information about the interventions
is likely to be unavailable, particularly for older studies.
Similarly, the current applicability of many of the
interventions can be questioned. The circumstances
operating in many of the studies may not be similar to
the challenges today. A simple example from the study
by Thomas et al,10 clearly applicable to UK primary care,
is that the rates of test ordering were in the region of
800 per 10 000 practice patients, whereas the equivalent
rates in a recent study in the South West were 2500 per
10000.5 The importance of this is accentuated by the
fact that interventions do not seem to have been
designed in the light of investigations to understand the
origin of the difﬁculties underlying the behaviour they
were attempting to address. Thus, in primary care, it is
widely accepted that the reason why GPs order tests is
frequently not for medical reasons,49 yet most interven-
tions we encountered, such as education and guidelines,
assume that lack of medical knowledge is the underlying
difﬁculty. Our own investigations of GPs’ reasons why
TFT ordering rates might vary, included many factors
such as quality of computer systems, communication
with hospital systems, general attitude to risk, involve-
ment of other members of the primary care team in test
ordering and patient expectations, all issues which are
unlikely to have been addressed by any of the interven-
tions we observed.7 Our concerns about openness to
bias of the included studies and possibility of publication
and outcome reporting bias reinforce our circumspec-
tion about whether the evidence reviewed is good
enough to implement.
Given the fact that the majority of TFTs are ordered
by GPs in the UK5 and that guidelines for the use of
these tests in primary care already exist (though appear
to be ineffective), interventions that raise clinicians’
awareness of these guidelines, ‘translate’ them into easy
to follow rules and embed them in decision aids are
potentially effective combination. This review suggests
that most interventions succeed (albeit in the limited
way described above), so it is probable that an interven-
tion can be designed that would work in UK primary
care. Other factors will still be relevant, as highlighted
by the qualitative study, such as lack of communication,
problems with storage and retrieval of previous results,
and lack of local protocols that structure the ordering of
TFTs in accordance with the existing guidelines.7
Conclusions and policy implications
The systematic review we have conducted indicates that
behaviour change interventions can modify TFT order-
ing. While a starting point for implementation, we do
not believe the evidence base is complete and strongly
recommend further research. As well as overcoming the
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limitations highlighted concerning bias, improving
details of the interventions to be implemented and
improving applicability to current challenges, new
research can also address questions barely touched on
by the existing evidence base. Such questions include
the effectiveness of interventions like computerised test
ordering systems (order.com’s) in primary care, how to
maintain the effect on test ordering over several years
and cost-effectiveness. The scale of the problem is
important in this regard. While a few of the included
studies had large effects, most only had small effects
which would not be large enough to impact for instance
on the sixfold variation in test ordering in primary care
observed in the South West5 or the even more extreme
variation observed across the UK.6
The current study also demonstrates that even though
reviewing the evidence with the target behaviour clearly
in mind is a more productive approach than looking at
similar behaviour change interventions applied to a wide
variety of targets, such an approach has limitations. For
instance, many studies targeting a wide range of test
ordering behaviour reported only average effect, even
when it was clear that the effect on the ordering of dif-
ferent tests was quite different. This limited the number
of studies available for inclusion and probably accounted
for the small number of studies evaluating speciﬁc inter-
ventions such as those based on computerised test order-
ing systems. Moreover, even when the studies reported
test-speciﬁc effects, they rarely investigated the reasons
for this variation and failed to provide explanation of
the observed differences. Given the poor methodo-
logical quality of many of the included studies, this
made it difﬁcult to draw reliable conclusions and
make recommendations. This suggests that although
similar reviews to this looking at the effectiveness of
behaviour change interventions on modifying the
ordering of other routine tests would be helpful, a
novel approach may be necessary. Such approach
could focus on similar test ordering behaviours rather
than similar tests and could incorporate wider range
of evidence able to demonstrate not only the effective-
ness of different interventions but also to provide
insight in the mechanisms behind speciﬁc behaviour
modiﬁcations.
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